MYCN and medulloblastoma: Interestingly, Mad3 is upregulated in mouse models of medulloblastoma [32] as well as human medulloblastoma samples [36], suggesting that like Nmyc (which coincidently was initially identified in an expression profiling study of purified GNPs treated with Shh [29]), Mad3 might play a role in tumor biogenesis.